Global News Aggregator
Credit Suisse is shifting its perspective on shares of Danaher as the company’s bioprocess business comes under pressure. Analyst Dan Leonard downgraded the medical stock to neutral from outperform, citing…
The new year should bring a boost to clean energy stocks, according to Raymond James. Despite solid underlying fundamentals, the sector had a dismal 2022 — the worst since the…
Apple has lost more than 20% this year, but Citi has six reasons to think the tech giant’s stock will rise in 2023. “We believe demand for Apple’s products and…
JPMorgan cut its iPhone shipment forecast for the December quarter once again as Apple faces the fallout from the temporary shutdown at one of its largest assembly plants. Analyst Samik…
It’s time to move to the sidelines on Starbucks , according to Deutsche Bank. Analyst Brian Mullan downgraded shares of Starbucks to hold from buy, saying gains for the stock…
The sell-off in telemedicine name GoodRx is overdone, and now is a good time to buy the stock, according to Citi. Analyst Daniel Grosslight initiated coverage on GoodRx with a…
Shares of Walgreens Boots Alliance offer an attractive risk-reward to investors as the company transforms into a health care services-focused business, according to Cowen. Analyst Charles Rhyee upgraded the stock…
Citi says it’s time for investors to load up on shares of BP . Analyst Alastair Syme upgraded the oil stock to a buy from a neutral rating, saying BP…
It may be time to buy Comerica after its recent stock underperformance, according to Raymond James. Analyst Michael Rose upgraded shares to outperform from market perform. The analyst also has…
Bank of America says the collapse of FTX is clouding the outlook for Coinbase . Analyst Jason Kupferberg downgraded shares of Coinbase to neutral from buy, citing “contagion risk” for…